Total Syntheses of Nannocystins A and A0, Two Elongation Factor 1 Inhibitors
Authors:
- 6 September 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 18 (18) , 4702-4705
Abstract
Asymmetric total syntheses of nannocystins A and A0 were achieved in a convergent route starting from simple materials. Nannocystin family natural products bear potent anticancer activity as elongation factor 1 inhibitors. In this synthesis, the challenging tertiary amide bond was constructed by peptide coupling between an acyl chloride and a secondary amine. A late-stage ring-closing metathesis reaction successfully rendered the macrocycle. This efficient synthetic strategy should be applicable to other nannocystins and analogues and therefore should benefit future structure–activity relationship studies.Keywords
Funding Information
- University at Albany
This publication has 49 references indexed in Scilit:
- Natural Products as Sources of New Drugs from 1981 to 2014Journal of Natural Products, 2016
- Role of Marine Natural Products in the Genesis of Antiviral AgentsChemical Reviews, 2015
- Natural Products in Medicine: Transformational Outcome of Synthetic ChemistryJournal of Medicinal Chemistry, 2014
- A Historical Overview of Natural Products in Drug DiscoveryMetabolites, 2012
- Natural products: An evolving role in future drug discoveryEuropean Journal of Medicinal Chemistry, 2011
- Structural and conformational features relevant to the anti‐tumor activity of calicheamicin γChirality, 2011
- Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling SymphonyJournal of Biological Chemistry, 2010
- mTOR and cancer therapyOncogene, 2006
- Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in YeastScience, 1991
- Calicheamicins: discovery, structure, chemistry, and interaction with DNAAccounts of Chemical Research, 1991